Steven Cohen’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-932
Closed -$22.2K – 4678
2026
Q2
$22.2K Buy
+932
New +$24.4K ﹤0.01% 3867
2025
Q3
– Sell
-24,717
Closed -$5.01M – 2759
2025
Q2
$5.01M Sell
24,717
-46,385
-65% -$7.3M 0.01% 967
2025
Q1
$8.59M Sell
71,102
-50,978
-42% -$7.43M 0.02% 738
2024
Q4
$17.7M Buy
+122,080
New +$14.8M 0.04% 494

Other funds holding ATYR

Steven Cohen's ATYR Position: Q3 2026 in Review

Steven Cohen sold out of aTyr Pharma (ATYR) in Q3 2026, closing a stake of 932 shares — an estimated $22.2K sold.

Steven Cohen first reported a position in ATYR in Q4 2024 and held it in 4 quarters. The position peaked at $17.7M in Q4 2024. 69 funds tracked by Wall St. Rank hold ATYR as of Q3 2026.

  • Steven Cohen reported no remaining aTyr Pharma position as of Q3 2026 after selling out during the quarter.
  • Steven Cohen sold 932 aTyr Pharma shares in Q3 2026, an estimated $22.2K.
  • Steven Cohen first reported a position in aTyr Pharma in Q4 2024 and held it in 4 quarters.
  • Steven Cohen's aTyr Pharma position peaked at $17.7M in Q4 2024.
  • 69 funds tracked by Wall St. Rank held aTyr Pharma as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.